Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 135-139, February 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kessel, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kessel, D.

Transport and Accumulation of Triazenoimidazoles by L1210 Cells1

David Kessel

Department of Pharmacology, University of Rochester School of Medicine, Rochester, New York 14620

Transport of 5-(dimethyltriazeno)imidazole-4-carboxamide (NSC 45388) and the 3,3-bis(2-chloroethyl) derivative (NSC 82196) was studied in vitro in L1210 cells and in drug-resistant sublines. Uptake of both compounds was temperature sensitive and apparently nonsaturable. Accumulated NSC 45388 could be removed from the cells by brief suspension in buffer at 37°. In contrast, accumulated NSC 82196 was not readily washed out. Under ultraviolet irradiation, NSC 45388 dissociates to form an unstable compound, presumably 5-diazoimidazole-4-carboxamide. The latter was extensively bound to L1210 cells, even at 0°. Sublines of L1210 selected for resistance to NSC 45388 and NSC 82196 showed no impairment in capacity for drug accumulation; retention of accumulated NSC 82196 labeled in the bis(chloroethyl) side chain was impaired in L1210/82196.

1 Supported by Contract NIH 69-39 with Chemotherapy, National Cancer Institute, NIH, Grant CA 11198-01 from the NIH, an institutional grant (GRSG), and funds from the Monroe Country Cancer and Leukemia Association.

Received 4/23/70. Accepted 9/29/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.